Trials / Completed
CompletedNCT01517607
Mesalazine (PENTASA®) in Ulcerative Colitis
Mesalazine (PENTASA®) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 506 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This non-interventional study examines whether the patient's level of information and the consideration of the patient's preference have a positive effect on the compliance and thus also on the therapeutic success.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mesalazine | Patient's treated with oral Mesalazine |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-01-25
- Last updated
- 2015-10-01
Locations
149 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01517607. Inclusion in this directory is not an endorsement.